Dan Dearborn is listed as an executive officer on 5 SEC Form D filings by 2 issuers between Jul 2019 and Nov 2025: TuHURA Biosciences, Inc./NV (Tampa, FL — biotechnology — 2025; $21.8M reported sold to 161 investors) and TuHURA Biosciences, Inc. (Tampa, FL — biotechnology — 2019–2023; $9.1M reported sold to 40 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 6 years. Across those companies the filings report $30.9M sold in total.
Listed alongside George Ng (4 shared filings), James Bianco (4 shared filings), Alan List (3 shared filings), James Manuso (3 shared filings), Kiran C Patel (3 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Dan. Each name links to their own page.
All 2 issuers belong to the sponsor group Tuhura Biosciences (2 issuers, $3.17M reported sold, 2013–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Tuhura Biosciences has 2 companies on file and $3.17M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Dan Dearborn and found 4 differences: Form D filed 16 days after the first sale; Form D filed 17 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.